Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program

被引:0
|
作者
Lattard, Claire [1 ]
Herledan, Chloe [1 ,2 ]
Reverdy, Thibaut [3 ]
Antherieu, Gabriel [4 ]
Caffin, Anne-Gaelle [1 ]
Cerfon, Marie-Anne [1 ]
Maire, Magali [1 ]
Rivat, Marine [1 ]
France, Stephanie [1 ]
Ghesquieres, Herve [4 ]
You, Benoit [2 ,3 ]
Freyer, Gilles [2 ,3 ]
Ranchon, Florence [1 ,2 ]
Rioufol, Catherine [1 ,2 ]
机构
[1] Clin Oncol, Hosp Civils Lyon, Unite Pharm, Groupement Hospitalier Sud, F-69495 Pierre Benite, France
[2] Univ Lyon 1, CICLY, EA 3738, F-69921 Lyon, Oullins, France
[3] Hosp Civils Lyon, Unite Pharm Clin oncol, Groupement Hospitalier Sud, F-69495 Pierre Benite, France
[4] Unite Hematol, Hosp Civils Lyon, Groupement Hospitalier Sud, F-69495 Pierre Benite, France
来源
ONCOLOGIST | 2024年 / 30卷 / 02期
关键词
oral anticancer agents; dose intensity; adherence; drug-drug interaction; patient-reported outcomes; RENAL-CELL CARCINOMA; CLINICAL PHARMACISTS; DRUG-INTERACTIONS; MEDICATION SAFETY; DOSE INTENSITY; CANCER; IMPACT; CARE; ADHERENCE; ONCOLOGY;
D O I
10.1093/oncolo/oyae241
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Healthcare professionals are faced with the new challenges of preventing and managing drug-related problems (DRPs) with oral anticancer therapy (OAT): side-effects, drug-drug interactions (DDIs), non-adherence, or medication errors. This study aims to assess the impact of ONCORAL, a real-life multidisciplinary care plan for cancer patients based on community and hospital follow-up, for the first OAT cycle.Methods A prospective cohort study was conducted between October 1, 2021 and October 1, 2022 including all outpatients starting OAT treatment. During the first OAT cycle, the program consists of 6 weekly scheduled face-to-face or phone consultations to prevent and manage DRPs. Nurse and pharmacist interventions (NPIs) are realized to optimize treatments (primary outcomes). Secondary outcomes included the relative dose intensity (RDI) of the first cycle.Results A total of 562 NPIs were performed by the ONCORAL team: that is, 87.1% of the 209 patients included, for a mean of 3.1 +/- 2.2 NPIs/patient. NPIs-concerned DRPs detected by the nurse and pharmacist (346, 61.6%), symptoms and/or adverse effects reported as PROs by the patient or family (138, 24.6%), or pathway issues (78, 13.9%). Seventy-three DDIs were detected and managed during medication review, in a quarter of patients (n = 54/209), leading to the discontinuation of a daily concomitant medication in 30 cases. The mean RDI at the end of the first cycle, calculated for 209 patients, was 83.1 +/- 23.9% (17.56-144.23).Conclusion In these ambulatory cancer patients, the interest in tailored monitoring of DRPs as a whole, including the prevention and management of drug interactions in addition to symptoms and adverse effects, is highlighted. Healthcare professionals are faced with the new challenges of preventing and managing drug-related problems with oral anticancer therapy. This study assessed ONCORAL, a real-life multidisciplinary care plan.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Bloodstream infections in a community hospital: A 25-year follow-up
    Scheckler, WE
    Bobula, JA
    Beamsley, MB
    Hadden, ST
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (12): : 936 - 941
  • [32] Follow-up at a Dutch addiction hospital and effectiveness of therapeutic community treatment
    van de Velde, JC
    Schaap, GE
    Land, H
    SUBSTANCE USE & MISUSE, 1998, 33 (08) : 1611 - 1627
  • [33] The myelomeningocele follow-up program: the Swedish initiative to ensuring multidisciplinary healthcare for individuals with myelomeningocele
    Alriksson-Schmidt, Ann
    Lundkvist, Annika Josenby
    Rimstedt, Amanda Burman
    Westbom, Lena
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2019, 19
  • [34] Pharmacist-Coordinated Multidisciplinary Hospital Follow-up Visits Improve Patient Outcomes
    Cavanaugh, Jamie J.
    Lindsey, Kimberly N.
    Shilliday, Betsy B.
    Ratner, Shana P.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (03): : 256 - 260
  • [35] DEPRESSED OUTPATIENTS TREATED WITH COGNITIVE THERAPY OR PHARMACOTHERAPY - A ONE-YEAR FOLLOW-UP
    KOVACS, M
    RUSH, AJ
    BECK, AT
    HOLLON, SD
    ARCHIVES OF GENERAL PSYCHIATRY, 1981, 38 (01) : 33 - 39
  • [36] Effects of an early rehabilitation program in COPD exacerbation, after an hospital discharge, one-year follow-up
    Dos Santos Carvalho, Filipe Goncalves
    Martinez Rivera, Carlos
    Boldo, Maria
    Garcia Olive, Ignasi
    Marin Tapia, Alicia
    Munoz Ferrer, Aida
    Stojanovic, Zoran
    Francoso Vicente, Alicia
    Baeza Mena, Sonia
    Moreno Garcia, Ana Belen
    Mendiluce Ochandorena, Leire
    Dura Mata, Maria Jose
    Ruiz Manzano, Juan
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [37] Do All Patients With Heart Failure Benefit From a Program for Early Follow-up After Hospital Discharge?
    Anguita Sanchez, Manuel
    Castillo Dominguez, Juan C.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2017, 70 (08): : 624 - 625
  • [38] Early dexamethasone therapy in preterm infants: A follow-up study
    Yeh, TF
    Lin, YJ
    Huang, CC
    Chen, YJ
    Lin, CH
    Lin, HC
    Hsieh, WS
    Lien, YJ
    PEDIATRICS, 1998, 101 (05) : art. no. - e7
  • [39] Optimizing link between community and hospital: implementation of an e-learning program for community pharmacists to follow-up liver transplant patients
    Berthy, Elise
    Ranouille, Pauline
    Escapoulade, Lucile
    de Courtilles, Marion Girard
    Largeau, Berenger
    Minier, Delphine
    Zaragoza, Laura
    Barbier, Louise
    Pourrat, Xarrier
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 240 - 241
  • [40] EARLY VAGOTOMIES AT HENRY FORD HOSPITAL - HISTORICAL VIGNETTE AND A FOLLOW-UP
    GRUENBERG, JC
    LAM, CR
    HENRY FORD HOSPITAL MEDICAL JOURNAL, 1977, 25 (01) : 37 - 44